12 Month Price Forecast For MLEC
Distance to MLEC Price Forecasts
MLEC Price Momentum
๐ค Considering MooLEC (MLEC)?
Join 5,000+ investors getting our exclusive market analysis every Monday & Thursday. Stay ahead of breakout opportunities.
Disclaimer: The information provided by Ticker Nerd is for educational and informational purposes only. It should not be considered financial or investment advice. Past performance is not indicative of future results. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions. Analyst ratings and price forecasts are sourced from Wall St analysts and other experts. These projections are speculative and do not guarantee future stock performance.
Data last updated: February 16, 2025 5:16 AM UTC
MLEC Analyst Ratings & Price Targets
Based on our analysis of 2 Wall Street analysts, MLEC has a bullish consensus with a median price target of $3.00 (ranging from $3.00 to $3.00). Currently trading at $0.68, the median forecast implies a 338.6% upside. This outlook is supported by 1 Buy, 0 Hold, and 0 Sell ratings.
Please note that analyst price targets are forward-looking estimates subject to substantial market, economic, and company-specific risks. Past performance does not guarantee future results, and actual stock performance may materially differ from these projections. Investors should conduct their own due diligence and consider their investment objectives and risk tolerance before making investment decisions.
MLEC Analyst Consensus
MLEC Price Target Range
Latest MLEC Stock Forecasts by Analyst
These are the latest 20 analyst ratings and price targets for MLEC.
Date | Firm | Analyst | Rating | Change | Price Target |
---|---|---|---|---|---|
Jan 30, 2024 | Maxim Group | Anthony Vendetti | Buy | Initiates | $6.00 |
Nov 22, 2022 | Cantor Fitzgerald | Overweight | Upgrade | $0.00 | |
Oct 20, 2022 | HC Wainwright & Co. | Buy | Maintains | $0.00 | |
Sep 26, 2022 | Wedbush | Outperform | Maintains | $0.00 | |
Sep 7, 2022 | Capital One | Overweight | Initiates | $0.00 |
Stocks Similar to Moolec Science S.A.
The following stocks are similar to MooLEC based on their market capitalization and industry sector. These similar stocks potentially provide investors with alternative investment opportunities within the same market segment.
Moolec Science S.A. (MLEC) Financial Data
Moolec Science S.A. has a market capitalization of $27.36M with a P/E ratio of -3.6x. The company generates $5.63M in trailing twelve-month revenue with a -130.0% profit margin.
Revenue growth is +68.3% quarter-over-quarter, while maintaining an operating margin of -193.0% and return on equity of -86.4%.
Valuation Metrics
Growth & Margins
Financial Health
๐ฅ Want More High-Potential Stock Ideas?
Join 5,000+ investors getting our research on stocks with massive upside potential.

Moolec Science S.A. (MLEC) Company Overview
About Moolec Science S.A.
Develops food ingredients using molecular farming.
Moolec Science SA generates revenue by creating innovative food ingredients for various markets, including human food, pet food, and animal feed. The company leverages molecular farming technology to produce high-quality products such as textured soy proteins and meat replacements.
Founded in 2020 and headquartered in Luxembourg, Moolec Science operates across the United States, Europe, and South America, positioning itself to capitalize on the growing demand for sustainable and alternative food sources.
Company Information
Sector
Healthcare
Industry
Biotechnology
Employees
52
CEO
Mr. Gaston Paladini M.B.A.
Country
Luxembourg
IPO Year
2023
Website
moolecscience.comMoolec Science S.A. (MLEC) Latest News & Analysis
Moolec Science SA (NASDAQ:MLEC) received USDA-APHIS regulatory clearance for its GE peas producing iron from bovine meat proteins, marking its third approval in 18 months for various GE products.
USDA's clearance of Moolec's GE peas enhances the company's market position, indicating regulatory approval eases market entry, potentially boosting investor confidence and stock value.
Moolec Science SA (NASDAQ:MLEC) reported a fourth-quarter update for FY 2024, highlighting an offtake agreement with a major CPG food and pet food company and a collaboration with Bunge.
Moolec's offtake agreement with a major CPG company and collaboration with Bunge indicate strong market confidence and potential revenue growth, positively impacting its stock valuation.
Moolec Science SA (NASDAQ:MLEC) will hold its Q4 2024 earnings conference call on October 2, 2024, at 8:30 AM ET, featuring key executives including the CEO and CFO.
Moolec Science's Q4 earnings call signals financial performance insights, key leadership discussions, and future strategy, influencing market perception and investment decisions.
Moolec Science SA (NASDAQ:MLEC) will release its Q4 and FY 2024 Business Update on October 2, 2024, before market open, followed by a conference call at 8:30am ET.
The upcoming business update from Moolec Science SA may provide insights into financial performance and strategic direction, influencing investor sentiment and stock valuation.
Moolec Received NASDAQ Bid Price Letter
5 months agoMoolec Science SA received a Nasdaq letter indicating its share price has been below $1.00 for 30 consecutive days, but it can still trade under symbol "MLEC" while addressing this issue.
Moolec Science's stock is at risk of delisting from Nasdaq due to its share price falling below $1. This could lead to reduced investor confidence and liquidity challenges.
Moolec Confirms US Harvest and Promising Yields for Plant-Grown Products GLASO(TM) and Piggy Sooy(TM) in October
5 months agoMoolec Science SA (NASDAQ:MLEC) confirmed the US harvest of its genetically engineered products GLASOโข and Piggy Sooyโข in October 2024, with 600 acres of safflower planted in Idaho.
The harvest confirmation for Moolec's genetically engineered products signals potential revenue growth and market expansion, impacting investor confidence and stock performance.
Frequently Asked Questions About MLEC Stock
What is Moolec Science S.A.'s (MLEC) stock forecast for 2025?
Based on our analysis of 2 Wall Street analysts, Moolec Science S.A. (MLEC) has a median price target of $3.00. The highest price target is $3.00 and the lowest is $3.00.
Is MLEC stock a good investment in 2025?
According to current analyst ratings, MLEC has 1 Buy ratings, 0 Hold ratings, and 0 Sell ratings. The stock is currently trading at $0.68. Always conduct your own research and consider your investment goals before making investment decisions.
What is the price prediction for MLEC stock?
Wall Street analysts predict MLEC stock could reach $3.00 in the next 12 months. This represents a 338.6% increase from the current price of $0.68. Please note that this is a projection by Wall Street analysts and not a guarantee.
What is Moolec Science S.A.'s business model?
Moolec Science SA generates revenue by creating innovative food ingredients for various markets, including human food, pet food, and animal feed. The company leverages molecular farming technology to produce high-quality products such as textured soy proteins and meat replacements.
What is the highest forecasted price for MLEC Moolec Science S.A.?
The highest price target for MLEC is $3.00 from at , which represents a 338.6% increase from the current price of $0.68.
What is the lowest forecasted price for MLEC Moolec Science S.A.?
The lowest price target for MLEC is $3.00 from at , which represents a 338.6% increase from the current price of $0.68.
What is the overall MLEC consensus from analysts for Moolec Science S.A.?
The overall analyst consensus for MLEC is bullish. Out of 2 Wall Street analysts, 1 rate it as Buy, 0 as Hold, and 0 as Sell, with a median price target of $3.00.
How accurate are MLEC stock price projections?
Stock price projections, including those for Moolec Science S.A., are based on various factors including financial models, market conditions, and analyst forecasts. While these predictions provide valuable insights, they should be considered alongside your own research and risk tolerance.